RxDoctor Payments Data

Solange Burnette, MD

Family Medicine · Jacksonville Beach, FLNPI 1336349935

Payments from drug & device makers

$5,746in general payments, 2019–2025

Across 320 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$808
  • AbbVie$654
  • GSK$614
  • Lilly USA, LLC$517
  • Amgen$463
  • AstraZeneca$406
  • plus $2K from 44 others

What the payments were for

  • Food & beverage$5,746100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,746 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$148,380
Medicare patients
488
Services billed
1,955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban91$88,572
TrulicityDulaglutide50$51,147
JardianceEmpagliflozin45$48,645
FarxigaDapagliflozin Propanediol35$33,013
OzempicSemaglutide32$30,077
JanuviaSitagliptin Phosphate25$29,227
MounjaroTirzepatide28$28,407
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$23,687
MyrbetriqMirabegron18$20,690
RybelsusSemaglutide14$20,055
WegovySemaglutide13$17,900
Nurtec OdtRimegepant Sulfate12$11,997
XareltoRivaroxaban16$11,651
Bevespi AerosphereGlycopyrrolate/Formoterol Fum13$5,604
DayvigoLemborexant15$4,983

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$380$100,569103 claims
Lilly USA, LLCTrulicity, Mounjaro$517$79,55478 claims
Novo NordiskOzempic, Rybelsus, Wegovy$808$68,03259 claims
Boehringer IngelheimJardiance$200$48,64545 claims
AstraZenecaFarxiga, Bevespi Aerosphere$406$38,61748 claims
MerckJanuvia$232$29,22725 claims
GSKTrelegy Ellipta$614$23,68732 claims
Astellas Pharma US IncMyrbetriq$43$20,69018 claims
Johnson & JohnsonXarelto$12$11,65116 claims
Eisai Inc.Dayvigo$17$4,98315 claims
AbbVieSynthroid$654$2,79336 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →